News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
239,469 Results
Type
Article (36249)
Company Profile (18)
Press Release (203202)
Multimedia
Podcasts (16)
Webinars (10)
Section
Business (75377)
Career Advice (498)
Deals (7433)
Drug Delivery (28)
Drug Development (29354)
Employer Resources (39)
FDA (4718)
Job Trends (4524)
News (115289)
Policy (7908)
Tag
Academia (2473)
Academic (1)
Accelerated approval (22)
Adcomms (15)
Allergies (74)
Alliances (13776)
ALS (68)
Alzheimer's disease (755)
Antibody-drug conjugate (ADC) (79)
Approvals (4808)
Artificial intelligence (162)
Autoimmune disease (55)
Automation (12)
Bankruptcy (68)
Best Places to Work (3680)
BIOSECURE Act (5)
Biosimilars (32)
Biotechnology (21)
Bladder cancer (53)
Brain cancer (35)
Breast cancer (245)
Cancer (1974)
Cardiovascular disease (164)
Career advice (443)
Career pathing (10)
CAR-T (106)
CDC (30)
Cell therapy (286)
Cervical cancer (14)
Clinical research (24646)
Collaboration (473)
Company closure (2)
Compensation (155)
Complete response letters (29)
COVID-19 (1452)
CRISPR (35)
C-suite (677)
Cystic fibrosis (44)
Data (2893)
Decentralized trials (2)
Denatured (6)
Depression (71)
Dermatology (27)
Diabetes (190)
Diagnostics (2379)
Digital health (11)
Diversity (6)
Diversity, equity & inclusion (17)
Drug discovery (80)
Drug pricing (46)
Drug shortages (7)
Duchenne muscular dystrophy (92)
Earnings (24779)
Editorial (23)
Employer branding (4)
Employer resources (39)
Events (28186)
Executive appointments (705)
FDA (5759)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (543)
Gene editing (82)
Generative AI (6)
Gene therapy (229)
GLP-1 (308)
Government (1463)
Grass and pollen (1)
Guidances (144)
Healthcare (6725)
HIV (19)
Huntington's disease (17)
IgA nephropathy (32)
Immunology and inflammation (66)
Immuno-oncology (25)
Indications (45)
Infectious disease (1573)
Inflammatory bowel disease (62)
Inflation Reduction Act (5)
Influenza (50)
Intellectual property (58)
Interviews (62)
IPO (3739)
IRA (19)
Job creations (949)
Job search strategy (406)
JPM (10)
Kidney cancer (10)
Labor market (27)
Layoffs (156)
Leadership (9)
Legal (1792)
Liver cancer (34)
Longevity (4)
Lung cancer (254)
Lymphoma (174)
Machine learning (14)
Management (11)
Manufacturing (212)
MASH (82)
Medical device (4393)
Medtech (4410)
Mergers & acquisitions (3978)
Metabolic disorders (418)
mRNA (69)
Multiple sclerosis (55)
NASH (8)
Neurodegenerative disease (146)
Neuropsychiatric disorders (35)
Neuroscience (1256)
Neurotech (1)
NextGen: Class of 2026 (2562)
Non-profit (1995)
Now hiring (11)
Obesity (145)
Opinion (66)
Ovarian cancer (81)
Pain (62)
Pancreatic cancer (98)
Parkinson's disease (123)
Partnered (10)
Patents (126)
Patient recruitment (225)
Peanut (24)
People (36156)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase 1 (7603)
Phase 2 (11050)
Phase 3 (8059)
Pipeline (2253)
Policy (106)
Postmarket research (1101)
Preclinical (3615)
Press Release (28)
Prostate cancer (105)
Psychedelics (33)
Radiopharmaceuticals (106)
Rare diseases (335)
Real estate (1750)
Recruiting (19)
Regulatory (6187)
Reports (10)
Research institute (1490)
Resumes & cover letters (51)
Rett syndrome (8)
RNA editing (6)
RSV (29)
Schizophrenia (59)
Series A (85)
Series B (48)
Service/supplier (1)
Sickle cell disease (44)
Special edition (6)
Spinal muscular atrophy (62)
Sponsored (8)
Startups (1371)
Stomach cancer (7)
Supply chain (13)
Tariffs (14)
The Weekly (10)
Vaccines (440)
Venture capital (25)
Weight loss (89)
Women's health (33)
Worklife (3)
Date
Last 7 days (176)
Last 30 days (684)
Last 365 days (9481)
2026 (2075)
2025 (9553)
2024 (10865)
2023 (13473)
2022 (16182)
2021 (18111)
2020 (17626)
2019 (16071)
2018 (12202)
2017 (11950)
2016 (11652)
2015 (13273)
2014 (10378)
2013 (9444)
2012 (9799)
2011 (9635)
2010 (8893)
Location
Africa (313)
Alabama (28)
Alaska (3)
Arizona (88)
Arkansas (7)
Asia (14389)
Australia (3262)
California (3813)
Canada (1179)
China (378)
Colorado (172)
Connecticut (165)
Delaware (90)
Europe (36898)
Florida (506)
Georgia (200)
Idaho (16)
Illinois (275)
India (14)
Indiana (155)
Iowa (9)
Japan (162)
Kansas (43)
Kentucky (11)
Louisiana (14)
Maine (28)
Maryland (440)
Massachusetts (2555)
Michigan (121)
Minnesota (200)
Mississippi (4)
Missouri (55)
Montana (13)
Nebraska (5)
Nevada (46)
New Hampshire (24)
New Jersey (1115)
New Mexico (12)
New York (1118)
North Carolina (557)
North Dakota (3)
Northern California (1978)
Ohio (149)
Oklahoma (11)
Oregon (9)
Pennsylvania (766)
Puerto Rico (5)
Rhode Island (21)
South America (378)
South Carolina (18)
Southern California (1454)
Tennessee (80)
Texas (617)
United States (13610)
Utah (115)
Virginia (87)
Washington D.C. (26)
Washington State (314)
West Virginia (3)
Wisconsin (32)
Wyoming (1)
239,469 Results for "georg august university goettingen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea
March 11, 2026
·
5 min read
Press Releases
George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement
March 16, 2026
·
7 min read
Press Releases
George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia
February 25, 2026
·
6 min read
Press Releases
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
September 23, 2025
·
4 min read
Press Releases
Avet Pharma Announces Leadership Transition: CEO George Svokos to Retire; Dan Lukasiewicz Promoted to Chief Commercial Officer
February 5, 2026
·
2 min read
Press Releases
Ashvattha Therapeutics Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships
January 9, 2026
·
3 min read
Press Releases
Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors
November 11, 2025
·
5 min read
Duchenne muscular dystrophy
Capricor Shares Rise as FDA Sets August Decision Date for Rejected Duchenne Therapy
Capricor Therapeutics’ deramiocel was rejected in July 2025, potentially caught between Nicole Verdun, a former top biologics regulator at the FDA, and outgoing Vinay Prasad, director of the Center for Biologics Evaluation and Research.
March 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
·
3 min read
Press Releases
Biofrontera Inc. Appoints George Jones as Chief Commercial Officer
August 12, 2025
·
6 min read
1 of 23,947
Next
